|
GSK and CureVac to develop next generation mRNA COVID-19 vaccines
|
04 February 2021 |
|
Vir Biotechnology and GSK announce NHS-supported AGILE study to evaluate VIR-7832 in the early treatment of COVID-19
|
15 January 2021 |
|
Vir Biotechnology and GSK announce start of NIH-sponsored ACTIV-3 trial evaluating VIR-7831 in hospitalised adults with COVID-19
|
17 December 2020 |
|
Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine programme to improve immune response in the elderly
|
11 December 2020 |
|
Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate
|
12 November 2020 |
|
Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19
|
07 October 2020 |
|
Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine
|
23 September 2020 |
|
Vir Biotechnology and GSK start phase 2/3 study of COVID-19 antibody treatment
|
31 August 2020 |
|
Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine
|
04 August 2020 |
|
GSK and CureVac announce strategic mRNA technology collaboration
|
21 July 2020 |
|
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
|
07 July 2020 |
|
GSK COVID-19 vaccine development collaboration with Clover Biopharmaceuticals begins clinical trials
|
25 June 2020 |
|
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19
|
20 April 2020 |
|
GSK and Vir Biotechnology enter collaboration to find coronavirus solutions
|
08 April 2020 |
|
First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis
|
03 March 2020 |
|
Clover and GSK announce research collaboration to evaluate coronavirus (COVID-19) vaccine candidate with pandemic adjuvant system
|
24 February 2020 |
|
FDA approves GSK's Voltaren Arthritis Pain for over-the-counter use in the United States
|
20 February 2020 |
|
CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus
|
05 February 2020 |
|
GSK completes transaction with Pfizer to form new world-leading Consumer Healthcare Joint Venture
|
06 August 2019 |
|
Nucala (mepolizumab) gains FDA approval for two new self-administration options
|
07 June 2019 |